(Q43330065)

19 November 2017

A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome (English)

1 reference

19 November 2017

1 reference

1 reference

placebo-controlled trial

1 reference

3

Vatn MH

1 reference

19 November 2017

Efskind PS

1

1 reference

PubMed ID

8734343

19 November 2017

Bernklev T

series ordinal

2

1 reference

19 November 2017

1 May 1996

1 reference

Scandinavian Journal of Gastroenterology

19 November 2017

1 reference

19 November 2017

31

1 reference

19 November 2017

5

1 reference

19 November 2017

463-468

1 reference

The irritable bowel syndrome: a paroxysmal motor disorder.

19 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

Inhibitory actions of loperamide on absorptive processes in rat small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

ABC of colorectal diseases. The irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

Psychological characteristics of patients with the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

A three-part controlled study of trimebutine in the treatment of irritable colon syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

Clinical approaches to irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

Double-blind placebo-controlled study of loperamide (Imodium) in chronic diarrhoea caused by ileocolic disease or resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

Psychological factors in the irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

Irritable Bowel Syndrome–Prognosis and Diagnostic Safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529609006766

10.3109/00365529609006766

21 January 2018

Identifiers

DOI

1 reference

19 November 2017

1 reference

PubMed ID

8734343